Abstract:The receptor binding domain (RBD) of the coronavirus spike protein (S) has been verified to be the main target for potent neutralizing antibodies (nAbs) in most coronaviruses, and the N-terminal domain (NTD) of some betacoronaviruses has also been indicated to induce nAbs. For alphacoronavirus HCoV-229E, its RBD has been shown to have neutralizing epitopes, and these epitopes could change over time. However, whether neutralizing epitopes exist on the NTD and whether these epitopes change like those of the RBD are still unknown. Here, we verified that neutralizing epitopes exist on the NTD of HCoV-229E. Furthermore, we characterized an NTD targeting nAb 5H10, which could neutralize both pseudotyped and authentic HCoV-229E VR740 in vitro. Epitope mapping indicated that 5H10 targeted motif E1 (147-167 aa) and identified F159 as critical for 5H10 binding. More importantly, our results revealed that motif E1 was highly conserved among clinical isolates except for F159. Further data proved that mutations at position 159 gradually appeared over time and could completely abolish the neutralizing ability of 5H10, supporting the notion that position 159 may be under selective pressure during the human epidemic. In addition, we also found that contemporary clinical serum has a stronger binding capacity for the NTD of contemporary strains than historic strains, proving that the epitope on the NTD could change over time. In summary, these findings define a novel neutralizing epitope on the NTD of HCoV-229E S and provide a theoretical basis for the design of vaccines against HCoV-229E or related coronaviruses. Importance Characterization of the neutralizing epitope of the spike (S) protein, the major invasion protein of coronaviruses, can help us better understand the evolutionary characteristics of these viruses and promote vaccine development. To date, the neutralizing epitope distribution of alphacoronaviruses is not well known. Here, we identified a neutralizing antibody that targeted the N-terminal domain (NTD) of the alphacoronavirus HCoV-229E S protein. Epitope mapping revealed a novel epitope that was not previously discovered in HCoV-229E. Further studies identified an important residue, F159. Mutations that gradually appeared over time at this site abolished the neutralizing ability of 5H10, indicating that selective pressure occurred at this position in the spread of HCoV-229E. Furthermore, we found that the epitopes within the NTD also changed over time. Taken together, our findings defined a novel neutralizing epitope and highlighted the role of the NTD in the future prevention and control of HCoV-229E or related coronaviruses.

Localization of Neutralization Epitopes on Adenovirus Fiber Knob from Species C.

Trimeric Knob Protein Specifically Distinguishes Neutralizing Antibodies to Different Human Adenovirus Species: Potential Application for Adenovirus Seroepidemiology

Characteristics of neutralizing antibodies to adenovirus capsid proteins in human and animal sera.

Broadly neutralizing monoclonal antibodies against human adenovirus types 55, 14p, 7, and 11 generated with recombinant type 11 fiber knob

Precise location of three novel linear epitopes using the generated monoclonal antibodies against the Knob domain of FAdV-4 surface structural protein, fiber1

Neutralizing epitopes mapping of human adenovirus type 14 hexon.

Identification of Two Novel Linear Neutralizing Epitopes Within the Hexon Protein of Canine Adenovirus Using Monoclonal Antibodies.

Hexon and Fiber of Adenovirus Type 14 and 55 Are Major Targets of Neutralizing Antibody but Only Fiber-Specific Antibody Contributes to Cross-Neutralizing Activity

Identification of a Critical and Conformational Neutralizing Epitope in Human Adenovirus Type 4 Hexon

The short fiber knobs of human adenovirus in species F elicit cross-neutralizing antibody responses

Identification and Application of Neutralizing Epitopes of Human Adenovirus Type 55 Hexon Protein

Expression and immunogenetic analysis of human adenovirus serotype 3 knob

An antigenic analysis of the adenovirus type 2 fibre polypeptide

Novel Potent Neutralizing Antibodies Revealed the Domain I of HCMV Glycoprotein B for Vaccine Design

Structural and Functional Studies on the Interaction of Adenovirus Fiber Knobs and Desmoglein 2

Characterization of Neutralizing Monoclonal Antibodies and Identification of a Novel Conserved C-Terminal Linear Epitope on the Hemagglutinin Protein of the H9N2 Avian Influenza Virus

Identification of a Novel Neutralizing Epitope on the N-Terminal Domain of the Human Coronavirus 229E Spike Protein.

Identification of a novel neutralizing epitope on the N-terminal domain of the HCoV-229E spike protein

Single Amino Acid Substitutions in the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Determine Viral Entry and Immunogenicity of a Major Neutralizing Domain

Neutralizing Epitopes in the Membrane-Proximal Region of Hiv-1 Gp41: Genetic Variability and Co-Variation

Design and Identification of a Novel Antiviral Affinity Peptide Against Fowl Adenovirus Serotype 4 (Fadv-4) by Targeting Fiber2 Protein.